New methods for creating complex carbohydrates
Selective Catalytic Strategies for Carbohydrate Synthesis
['FUNDING_R01'] · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · NIH-11009001
This study is working on new ways to create special sugars that are important for making better medicines, making it easier for scientists to produce these complex ingredients that help improve drug development.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (nih funded) |
| Locations | 1 site (CAMBRIDGE, UNITED STATES) |
| Trial ID | NIH-11009001 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative techniques to synthesize rare and unnatural carbohydrates that are crucial for the effectiveness of many pharmaceutical compounds. By employing selective radical reactions, the project aims to simplify the process of creating these complex sugars, which are often difficult to produce using traditional methods. The researchers will explore new catalytic strategies to manipulate the chemical bonds in carbohydrates, allowing for the efficient production of diverse monosaccharides and glycans. This work could lead to improved access to important bioactive molecules that can enhance drug development.
Who could benefit from this research
Good fit: Patients with conditions that could benefit from new carbohydrate-based therapies or medications would be ideal candidates for this research.
Not a fit: Patients who do not have conditions related to carbohydrate metabolism or who are not affected by carbohydrate-based therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective medications by improving the synthesis of critical carbohydrate-based compounds.
How similar studies have performed: Other research has shown promise in developing new synthetic methods for carbohydrates, indicating that this approach could yield significant advancements.
Where this research is happening
CAMBRIDGE, UNITED STATES
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY — CAMBRIDGE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WENDLANDT, ALISON — MASSACHUSETTS INSTITUTE OF TECHNOLOGY
- Study coordinator: WENDLANDT, ALISON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.